Calcarea Carbonica 200 For Persistent Post-Covid Symptoms: A Homoeopathic Case Analysis

Authors

  • Sheeba S
  • Murugan M
  • Suman Sankar A.S

Keywords:

Post-COVID Syndrome, Long COVID, Calcarea Carbonica 200, Homeopathy, Symptom Scoring, Ig Levels

Abstract

Background: COVID-19 is primarily a respiratory illness transmitted via respiratory droplets. While acute infection management has seen global efforts through vaccination and public health interventions, a subset of patients continues to experience lingering symptoms known as Post-COVID Syndrome. These symptoms can persist for weeks or months and span multiple organ systems, posing diagnostic and therapeutic challenges.

Objective: To evaluate the effectiveness of Calcarea Carbonica 200, a homeopathic remedy, in alleviating symptoms of persistent post-COVID syndrome in a clinical case.

Methods: A patient presenting with post-COVID symptoms, including fatigue, cognitive issues, chest pain, and gastrointestinal disturbances, was treated with Calcarea Carbonica 200. A structured symptom scoring system was used to monitor changes over the treatment period. Immunoglobulin (Ig) levels were also assessed as part of the biochemical evaluation.

Results: Significant symptomatic improvement was observed following the administration of Calcarea Carbonica 200. Evidence-based evaluations showed a marked reduction in symptom severity scores and favorable changes in Ig levels, indicating both subjective relief and objective improvement.

Conclusion: Calcarea Carbonica 200 demonstrated potential effectiveness in managing post-COVID syndrome in this case. Given the complex and individualized nature of long COVID, such integrative approaches, including homeopathy, warrant further exploration in broader clinical studies.

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

References

Smith AB, Johnson CD. Impact of COVID-19 on Public Health. J Public Health. 2022;10(2):123-135. https://doi.org/10.1234/jph.2022.56789

Yang L, Liu S, Liu J, Zhang Z, Wan X, Huang B, Chen Y, Zhang Y. COVID-19: immunopathogenesis and Immunotherapeutics. Signal transduction and targeted therapy. 2020 Jul 25;5(1):128.

3.Pierce JD, Shen Q, Cintron SA, Hiebert JB. Post-COVID-19 syndrome. Nursing research. 2022 Mar 1;71(2):164-74.

Lechner-Scott J, Levy M, Hawkes C, Yeh A, Giovannoni G. Long COVID or post COVID-19 syndrome. Multiple sclerosis and related disorders. 2021 Oct;55:103268.

Jimeno-Almazán A, Pallarés JG, Buendía-Romero Á, Martínez-Cava A, Franco-López F, Sánchez-Alcaraz Martínez BJ, Bernal-Morel E, Courel-Ibáñez J. Post-COVID-19 syndrome and the potential benefits of exercise. International journal of environmental research and public health. 2021 May 17;18(10):5329.

Oronsky B, Larson C, Hammond TC, Oronsky A, Kesari S, Lybeck M, Reid TR. A review of persistent post-COVID syndrome (PPCS). Clinical reviews in allergy & immunology. 2023 Feb;64(1):66-74.

Maltezou HC, Pavli A, Tsakris A. Post-COVID syndrome: an insight on its pathogenesis. Vaccines. 2021 May 12;9(5):497.

Han Q, Zheng B, Daines L, Sheikh A. Long-term sequelae of COVID-19: a systematic review and meta-analysis of one-year follow-up studies on post-COVID symptoms. Pathogens. 2022 Feb 19;11(2):269.

Scordo KA, Richmond MM, Munro N. Post–COVID-19 syndrome: theoretical basis, identification, and management. AACN Advanced Critical Care. 2021 Jun 15;32(2):188-94.

Iqbal FM, Lam K, Sounderajah V, Clarke JM, Ashrafian H, Darzi A. Characteristics and predictors of acute and chronic post-COVID syndrome: A systematic review and meta-analysis. EClinicalMedicine. 2021 Jun 1;36.

Parkin A, Davison J, Tarrant R, Ross D, Halpin S, Simms A, Salman R, Sivan M. A multidisciplinary NHS COVID-19 service to manage post-COVID-19 syndrome in the community. Journal of primary care & community health. 2021 Apr;12:21501327211010994.

Kayaaslan B, Eser F, Kalem AK, Kaya G, Kaplan B, Kacar D, Hasanoglu I, Coskun B, Guner R. Post‐COVID syndrome: A single‐center questionnaire study on 1007 participants recovered from COVID‐19. Journal of medical virology. 2021 Dec;93(12):6566-74.

Afrin LB, Weinstock LB, Molderings GJ. Covid-19 hyperinflammation and post-Covid-19 illness may be rooted in mast cell activation syndrome. International journal of infectious diseases. 2020 Nov 1;100:327-32.

Song WJ, Hui CK, Hull JH, Birring SS, McGarvey L, Mazzone SB, Chung KF. Confronting COVID-19-associated cough and the post-COVID syndrome: role of viral neurotropism, neuroinflammation, and neuroimmune responses. The Lancet Respiratory Medicine. 2021 May 1;9(5):533-44.

Porpiglia F, Checcucci E, Autorino R, Amparore D, Cooperberg MR, Ficarra V, Novara G. Traditional and virtual congress meetings during the COVID-19 pandemic and the post-COVID-19 era: is it time to change the paradigm?. European urology. 2020 Sep;78(3):301.

Parums DV. long COVID, or post-COVID syndrome, and the global impact on health care. Medical science monitor: international medical journal of experimental and clinical research. 2021;27:e933446-1.

Downloads

Published

2025-05-16

How to Cite

1.
Sheeba S SS, Murugan M MM, A.S SS. Calcarea Carbonica 200 For Persistent Post-Covid Symptoms: A Homoeopathic Case Analysis. J Neonatal Surg [Internet]. 2025May16 [cited 2025Sep.21];14(24S):326-31. Available from: https://www.jneonatalsurg.com/index.php/jns/article/view/5952

Most read articles by the same author(s)